Global Prophylactic Human Vaccine Market Research Report Forecast 2017-2021

July 2017 | 118 pages | ID: GE795110114EN
S&P Consulting

Abstracts

The Global Prophylactic Human Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Prophylactic Human Vaccine industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Prophylactic Human Vaccine market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Prophylactic Human Vaccine Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer

Global Prophylactic Human Vaccine Market: Product Segment Analysis
Type 1
Type 2
Type 3


Global Prophylactic Human Vaccine Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PROPHYLACTIC HUMAN VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Prophylactic Human Vaccine
1.2 Prophylactic Human Vaccine Market Segmentation by Type
  1.2.1 Global Production Market Share of Prophylactic Human Vaccine by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Prophylactic Human Vaccine Market Segmentation by Application
  1.3.1 Prophylactic Human Vaccine Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Prophylactic Human Vaccine Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Prophylactic Human Vaccine (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON PROPHYLACTIC HUMAN VACCINE INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL PROPHYLACTIC HUMAN VACCINE MARKET COMPETITION BY MANUFACTURERS

3.1 Global Prophylactic Human Vaccine Production and Share by Manufacturers (2015 and 2016)
3.2 Global Prophylactic Human Vaccine Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Prophylactic Human Vaccine Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution, Production Area and Product Type
3.5 Prophylactic Human Vaccine Market Competitive Situation and Trends
  3.5.1 Prophylactic Human Vaccine Market Concentration Rate
  3.5.2 Prophylactic Human Vaccine Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL PROPHYLACTIC HUMAN VACCINE PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Prophylactic Human Vaccine Production by Region (2012-2017)
4.2 Global Prophylactic Human Vaccine Production Market Share by Region (2012-2017)
4.3 Global Prophylactic Human Vaccine Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL PROPHYLACTIC HUMAN VACCINE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Prophylactic Human Vaccine Consumption by Regions (2012-2017)
5.2 North America Prophylactic Human Vaccine Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Prophylactic Human Vaccine Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Prophylactic Human Vaccine Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Prophylactic Human Vaccine Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Prophylactic Human Vaccine Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Prophylactic Human Vaccine Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL PROPHYLACTIC HUMAN VACCINE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Prophylactic Human Vaccine Production and Market Share by Type (2012-2017)
6.2 Global Prophylactic Human Vaccine Revenue and Market Share by Type (2012-2017)
6.3 Global Prophylactic Human Vaccine Price by Type (2012-2017)
6.4 Global Prophylactic Human Vaccine Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL PROPHYLACTIC HUMAN VACCINE MARKET ANALYSIS BY APPLICATION

7.1 Global Prophylactic Human Vaccine Consumption and Market Share by Application (2012-2017)
7.2 Global Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL PROPHYLACTIC HUMAN VACCINE MANUFACTURERS ANALYSIS

8.1 Bavarian Nordic A/S
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 BiondVax Pharmaceuticals Ltd
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Bharat Biotech International Limited
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 GlaxoSmithKline
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Hualan Biological Engineering
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Janssen Pharmaceuticals
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 MedImmune
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Merck
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 Pfizer
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview

CHAPTER 9 PROPHYLACTIC HUMAN VACCINE MANUFACTURING COST ANALYSIS

9.1 Prophylactic Human Vaccine Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Prophylactic Human Vaccine

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Prophylactic Human Vaccine Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL PROPHYLACTIC HUMAN VACCINE MARKET FORECAST (2017-2021)

13.1 Global Prophylactic Human Vaccine Production, Revenue Forecast (2017-2021)
13.2 Global Prophylactic Human Vaccine Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Prophylactic Human Vaccine Production Forecast by Type (2017-2021)
13.4 Global Prophylactic Human Vaccine Consumption Forecast by Application (2017-2021)
13.5 Prophylactic Human Vaccine Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prophylactic Human Vaccine
Figure Global Production Market Share of Prophylactic Human Vaccine by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Prophylactic Human Vaccine Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Prophylactic Human Vaccine Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Prophylactic Human Vaccine Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Prophylactic Human Vaccine Capacity of Key Manufacturers (2015 and 2016)
Table Global Prophylactic Human Vaccine Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Prophylactic Human Vaccine Capacity of Key Manufacturers in 2015
Figure Global Prophylactic Human Vaccine Capacity of Key Manufacturers in 2016
Table Global Prophylactic Human Vaccine Production of Key Manufacturers (2015 and 2016)
Table Global Prophylactic Human Vaccine Production Share by Manufacturers (2015 and 2016)
Figure 2015 Prophylactic Human Vaccine Production Share by Manufacturers
Figure 2016 Prophylactic Human Vaccine Production Share by Manufacturers
Table Global Prophylactic Human Vaccine Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Prophylactic Human Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Prophylactic Human Vaccine Revenue Share by Manufacturers
Table 2016 Global Prophylactic Human Vaccine Revenue Share by Manufacturers
Table Global Market Prophylactic Human Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Prophylactic Human Vaccine Average Price of Key Manufacturers in 2015
Table Manufacturers Prophylactic Human Vaccine Manufacturing Base Distribution and Sales Area
Table Manufacturers Prophylactic Human Vaccine Product Type
Figure Prophylactic Human Vaccine Market Share of Top 3 Manufacturers
Figure Prophylactic Human Vaccine Market Share of Top 5 Manufacturers
Table Global Prophylactic Human Vaccine Capacity by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Capacity Market Share by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Prophylactic Human Vaccine Capacity Market Share by Regions
Table Global Prophylactic Human Vaccine Production by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Production and Market Share by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Production Market Share by Regions (2012-2017)
Figure 2015 Global Prophylactic Human Vaccine Production Market Share by Regions
Table Global Prophylactic Human Vaccine Revenue by Regions (2012-2017)
Table Global Prophylactic Human Vaccine Revenue Market Share by Regions (2012-2017)
Table 2015 Global Prophylactic Human Vaccine Revenue Market Share by Regions
Table Global Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table China Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table India Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Prophylactic Human Vaccine Consumption Market by Regions (2012-2017)
Table Global Prophylactic Human Vaccine Consumption Market Share by Regions (2012-2017)
Figure Global Prophylactic Human Vaccine Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Prophylactic Human Vaccine Consumption Market Share by Regions
Table North America Prophylactic Human Vaccine Production, Consumption, Import & Export (2012-2017)
Table Europe Prophylactic Human Vaccine Production, Consumption, Import & Export (2012-2017)
Table China Prophylactic Human Vaccine Production, Consumption, Import & Export (2012-2017)
Table Japan Prophylactic Human Vaccine Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Prophylactic Human Vaccine Production, Consumption, Import & Export (2012-2017)
Table India Prophylactic Human Vaccine Production, Consumption, Import & Export (2012-2017)
Table Global Prophylactic Human Vaccine Production by Type (2012-2017)
Table Global Prophylactic Human Vaccine Production Share by Type (2012-2017)
Figure Production Market Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure 2015 Production Market Share of Prophylactic Human Vaccine by Type
Table Global Prophylactic Human Vaccine Revenue by Type (2012-2017)
Table Global Prophylactic Human Vaccine Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Prophylactic Human Vaccine by Type (2012-2017)
Figure 2015 Revenue Market Share of Prophylactic Human Vaccine by Type
Table Global Prophylactic Human Vaccine Price by Type (2012-2017)
Figure Global Prophylactic Human Vaccine Production Growth by Type (2012-2017)
Table Global Prophylactic Human Vaccine Consumption by Application (2012-2017)
Table Global Prophylactic Human Vaccine Consumption Market Share by Application (2012-2017)
Figure Global Prophylactic Human Vaccine Consumption Market Share by Application in 2015
Table Global Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
Figure Global Prophylactic Human Vaccine Consumption Growth Rate by Application (2012-2017)
Table Bavarian Nordic A/S Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bavarian Nordic A/S Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Bavarian Nordic A/S Prophylactic Human Vaccine Market Share (2012-2017)
Table BiondVax Pharmaceuticals Ltd Basic Information, Manufacturing Base, Production Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table BiondVax Pharmaceuticals Ltd Prophylactic Human Vaccine Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bharat Biotech International Limited Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited Prophylactic Human Vaccine Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prophylactic Human Vaccine Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Hualan Biological Engineering Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Prophylactic Human Vaccine Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Pharmaceuticals Prophylactic Human Vaccine Market Share (2012-2017)
Table MedImmune Basic Information, Manufacturing Base, Production Area and Its Competitors
Table MedImmune Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Prophylactic Human Vaccine Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Prophylactic Human Vaccine Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Prophylactic Human Vaccine Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prophylactic Human Vaccine Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prophylactic Human Vaccine
Figure Manufacturing Process Analysis of Prophylactic Human Vaccine
Figure Prophylactic Human Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Prophylactic Human Vaccine Major Manufacturers in 2015
Table Major Buyers of Prophylactic Human Vaccine
Table Distributors/Traders List
Figure Global Prophylactic Human Vaccine Production and Growth Rate Forecast (2017-2021)
Figure Global Prophylactic Human Vaccine Revenue and Growth Rate Forecast (2017-2021)
Table Global Prophylactic Human Vaccine Production Forecast by Regions (2017-2021)
Table Global Prophylactic Human Vaccine Consumption Forecast by Regions (2017-2021)
Table Global Prophylactic Human Vaccine Production Forecast by Type (2017-2021)
Table Global Prophylactic Human Vaccine Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Bavarian Nordic A/S
BiondVax Pharmaceuticals Ltd
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA
Serum Institute of India Pvt
Shanghai BravoBio